Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
Authors:
- Malin K.B. JonssonMJMalin K.B. Jonsson
- Göran DukerGDGöran Duker
- Charlotte TroppCTCharlotte Tropp
- Birgit AnderssonBABirgit Andersson
- Peter SartipyPSPeter Sartipy
- Marc A. VosMVMarc A. Vos
- Toon A.B. van VeenTVToon A.B. van Veen
- 1 May 2010
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 4 (3) , 189-200
Abstract
No abstract availableKeywords
Funding Information
- ZonMW-NWO (114000102)
This publication has 39 references indexed in Scilit:
- Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytesStem Cell Research, 2010
- In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived CardiomyocytesStem Cells and Development, 2009
- Human embryonic stem cell-derived cardiomyocytes: drug discovery and safety pharmacologyExpert Opinion on Drug Discovery, 2007
- Assessing predictors of drug-induced torsade de pointesTrends in Pharmacological Sciences, 2003
- Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac MyocytesCirculation Research, 2003
- Divergent expression of delayed rectifier K+ channel subunits during mouse heart developmentCardiovascular Research, 2001
- Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is AntiarrhythmicCirculation, 2001
- Repercussions of pharmacologic reduction in ionic currents on action potential configuration in rabbit Purkinje fibers: Are they indicative of proarrhythmic potential?Drug Development Research, 1999
- The Controversial M CellJournal of Cardiovascular Electrophysiology, 1999
- Lidocaine and Nisoldipine Attenuate Almokalant-Induced Dispersion of Repolarization and Early Afterdepolarizations In VitroJournal of Cardiovascular Electrophysiology, 1996